Brief: Ryvu Therapeutics's Project On Recommendation List For 3.1 Mln Zloty Subsidy
29/11/2024 17:12
Nov 29 (Reuters) - Ryvu Therapeutics SA RVU.WA :
* 'INFRAADC' PROJECT INCLUDED IN FUNDING RECOMMENDATION LIST
FOR
3.1 MILLION ZLOTY SUBSIDY
* PROJECT'S TOTAL VALUE AT 7.5 MILLION ZLOTYS
Source text: ID:nEM1LZDFKa
Further company coverage: RVU.WA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Ryvu Therapeutics SA
See all newsBrief: Ryvu Therapeutics Q1 Net Loss 12.6 Million Zlotys
Brief: Ryvu Therapeutics Updates Romacyclib Development Strategy
Brief: Ryvu Therapeutics FY Net Loss At 101.2 Mln Zlotys
Brief: Ryvu Therapeutics Extends Research Collaboration And Exclusive License Agreement With BioNTech Until Nov 29, 2028
Brief: Ryvu Therapeutics Signs Grant Agreement With Poland's NCBR For PERO Project